Source: Atherosclerosis Supplements. Conference titles: Congress of the European-Atherosclerosis Society (EAS). Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, LIPOPROTEÍNAS LDL
ABNT
CÉSAR, F. A et al. New thiazolidine-2,4-diones improve lipid profile and dow-regulate pro-inflammatory gene expression in LDL receptor-deficient mice. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 maio 2024. , 2011APA
César, F. A., Rudnicki, M., Saito, C. A. I., Galdino, S. L., Lima, M. C. A., Pitta, I. da R., & Abdalla, D. S. P. (2011). New thiazolidine-2,4-diones improve lipid profile and dow-regulate pro-inflammatory gene expression in LDL receptor-deficient mice. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
César FA, Rudnicki M, Saito CAI, Galdino SL, Lima MCA, Pitta I da R, Abdalla DSP. New thiazolidine-2,4-diones improve lipid profile and dow-regulate pro-inflammatory gene expression in LDL receptor-deficient mice. Atherosclerosis Supplements. 2011 ; 12( 1): 83 res. 387.[citado 2024 maio 03 ]Vancouver
César FA, Rudnicki M, Saito CAI, Galdino SL, Lima MCA, Pitta I da R, Abdalla DSP. New thiazolidine-2,4-diones improve lipid profile and dow-regulate pro-inflammatory gene expression in LDL receptor-deficient mice. Atherosclerosis Supplements. 2011 ; 12( 1): 83 res. 387.[citado 2024 maio 03 ]